92 related articles for article (PubMed ID: 21415769)
1. Could complement C4 be an alternative to biopsy for chronic hepatitis B histopathologic findings?
Bugdaci MS; Alkim C; Karaca C; Kesici B; Bayraktar B; Sokmen M
J Clin Gastroenterol; 2011; 45(5):449-55. PubMed ID: 21415769
[TBL] [Abstract][Full Text] [Related]
2. Viral load speaks little about toll on liver.
Mahtab MA; Rahman S; Khan M; Kamal M; Mamun AA; Karim MF
Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):483-6. PubMed ID: 17897910
[TBL] [Abstract][Full Text] [Related]
3. Serum complement C4 in chronic hepatitis C: correlation with histopathologic findings and disease activity.
Buğdaci MS; Karaca C; Alkim C; Kesıcı B; Bayraktar B; Sökmen M
Turk J Gastroenterol; 2012 Feb; 23(1):33-7. PubMed ID: 22505377
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin and complement depositions in the liver of chronic hepatitis patients.
Vasei M; Monabbati A; Alizadeh-Naeeni M; Houshmand S; Azarpira N; Lankarani KB; Mosallaee M; Taghavi Sa; Geramizadeh B; Saberi-Firouzi M; Imaniyeh MH
Hepatogastroenterology; 2008; 55(84):1066-70. PubMed ID: 18705329
[TBL] [Abstract][Full Text] [Related]
5. [Relation of serological markers of hepatitis B virus and alanine transaminase to hepatic tissue pathology in patients with chronic hepatitis B].
Yang XY; Wen FY; Wu JL; Zhou HJ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):892-3. PubMed ID: 16793626
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of liver biopsy in Egyptian HBeAg-negative chronic hepatitis B patients at initial presentation: implications for therapy.
El-Zayadi AR; Badran HM; Saied A; Shawky S; Attia Mel-D; Zalata K
Am J Gastroenterol; 2009 Apr; 104(4):906-11. PubMed ID: 19293791
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong.
Chan HL; Leung NW; Hussain M; Wong ML; Lok AS
Hepatology; 2000 Mar; 31(3):763-8. PubMed ID: 10706570
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of quantitative hepatitis B virus DNA levels in serum and liver biopsy samples of chronic hepatitis B patients].
Rüzgar M; Cetin Akhan S; Vahaboğlu H
Mikrobiyol Bul; 2008 Apr; 42(2):283-91. PubMed ID: 18697426
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of clinical and pathological features of chronic hepatitis B with hepatic steatosis].
Mi YQ; Liu YG; Xu L; Fan JG; Zhang H; Ping L; Shi RF
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):817-20. PubMed ID: 19958639
[TBL] [Abstract][Full Text] [Related]
10. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of HBV DNA load in patients with chronic hepatitis B infection.
Madan K; Batra Y; Jha JK; Kumar S; Kalra N; Paul SB; Singh R; Duttagupta S; Panda SK; Acharya SK
Trop Gastroenterol; 2008; 29(2):84-90. PubMed ID: 18972767
[TBL] [Abstract][Full Text] [Related]
12. [Histological changes in the livers of chronic hepatitis B patients with persistently normal serum alanine transaminase levels].
Gui HL; Xie Q; Wang H; Cai W; Lin ZM; Jiang S; Xu P; Zhou XQ; Guo Q; Yu H
Zhonghua Gan Zang Bing Za Zhi; 2007 Dec; 15(12):881-5. PubMed ID: 18171518
[TBL] [Abstract][Full Text] [Related]
13. Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors.
Peng D; Han Y; Ding H; Wei L
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1082-8. PubMed ID: 18707599
[TBL] [Abstract][Full Text] [Related]
14. [Relationship among pathological changes in Liver tissues and level of serum HBV DNA, HBeAg and ALT of 194 patients with chronic hepatitis B].
Zhao DY; Qin YQ; Tang XM; Liu GZ; Zheng W; Nong HR; Song JJ; Xie QY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):35-7. PubMed ID: 17429530
[TBL] [Abstract][Full Text] [Related]
15. [Role of hepatitis C virus superinfection in hepatic pathologic changes of patients with chronic hepatitis B: a retrospective short-term and long-term comparative study].
Shang QH; Yu JG; Xu CZ; Xiao DM; Yin YM; Chen CX; Zhang GS
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):32-4. PubMed ID: 16201468
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B.
Lee KG; Seo YS; An H; Um SH; Jung ES; Keum B; Yim HJ; Jeen YT; Chun HJ; Kim CD; Ryu HS
J Gastroenterol Hepatol; 2010 Jan; 25(1):94-100. PubMed ID: 19793171
[TBL] [Abstract][Full Text] [Related]
17. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
[TBL] [Abstract][Full Text] [Related]
18. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
[TBL] [Abstract][Full Text] [Related]
19. Correlation of liver stiffness and histological features in healthy persons and in patients with occult hepatitis B, chronic active hepatitis B, or hepatitis B cirrhosis.
Fung J; Lai CL; Chan SC; But D; Seto WK; Cheng C; Wong DK; Lo CM; Fan ST; Yuen MF
Am J Gastroenterol; 2010 May; 105(5):1116-22. PubMed ID: 19920809
[TBL] [Abstract][Full Text] [Related]
20. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
